KOREA WHO

Kim Jin-woo Kim Michael J. is Vice Chairman and CEO of Prestige Biologics.

He was born on June 8, 1964.

He graduated from the Department of Business Administration at New York University and completed the MBA program at New York University’s Graduate School of Business.

After passing the CPA exam, he worked as an accountant at a joint accounting firm and at EYC Accounting Corporation, and later served as a consultant at KPMG.

He worked at Korea Exchange Bank as an investigator and inspector, and then served as Head of the Asia Division (Director) of Prestige Life Science in the United States before becoming CEO of PW Genetics Korea in 2001.

He later served as Managing Executive of Quaiion in Singapore, Co-CEO of Narae Systems, and CEO of Medikenetics.

In July 2015, he founded Prestige Biopharma with Chairwoman Park So-yeon to engage in the contract development and manufacturing of biopharmaceuticals.

He is an inside director of the parent company, Prestige Biopharma, an inside director of Mason Partners, a Singapore-based investment firm and the largest shareholder of Prestige Biopharma, and an inside director of Quaiion in Singapore.

Marking the company’s tenth year since its founding, he declared 2025 as “the first year of growth,” when orders and production will begin in earnest.

#PrestigeBiologics #PrestigeBiopharma #KimJinwoo #biopharmaceutical #CDMO #Singapore #MasonPartners #Quaiion #KoreaExchangeBank #MBA